Skip to Main Content

Marta San Luciano

MD

Neurologist
Runner, Parkinson's disease specialist and mother of three

Dr. Marta San Luciano specializes in diagnosing and managing movement disorders, including Parkinson's disease, dystonia, essential tremor and myoclonus. She has special interests in caring for patients whose genetic background may increase their risk of Parkinson's disease and dystonia, and in developing biomarkers and measuring outcomes in movement disorders.

San Luciano received her medical degree from the University of Navarra in Spain and earned a master's degree in clinical research methods from the Albert Einstein College of Medicine. She completed an internship in internal medicine at Metropolitan Hospital Center in New York and a residency in neurology at Boston University Medical Center. She also served as a clinical and research fellow in movement disorders at Beth Israel Deaconess Medical Center in New York.

In 2008, San Luciano was awarded a Clinical Research Training Fellowship by the American Academy of Neurology. She is an active member of the American Academy of Neurology, International Parkinson and Movement Disorder Society and Parkinson Study Group.

  • Education

    University of Navarre School of Medicine, 2002

  • Residencies

    Boston University Medical Center, 2007

  • Fellowships

    Beth Israel Deaconess Medical Center, 2010

  • Board Certifications

    Neurology, American Board of Psychiatry and Neurology

  • Academic Title

    Professor

  • Languages

    Spanish

The joy of practicing medicine for me is connecting with my patients and improving quality of life for those affected with neurological illness.

Where I see patients (2)

    Decorative Caduceus

    Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Youn...

    This is the primary motor outcome measure. It is the Movement Disorder-Childhood Rating Scale 4-18 Revised (MD-CRS 4-18 R). The MD-CRS 4-18 R is a validated tool aimed to evaluate movement disorders in developmental age. It is par...

    Recruiting

    More about this study
    See all clinical trials

    Translation, please

    We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.

    Request an interpreter

    Share